🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀AI for biology is transforming drug discovery, and top pharma companies are making it a part of their strategy. And when AstraZeneca talks about it, they talk about Turbine - at least in this article. Krishna Bulusu, AstraZeneca’s Senior Director of Oncology Data Science, sees

💡Turbine's simulations, even without training on SN38 combination datasets, accurately identified that SLFN11 gene knockout (KO) contributes to non-small cell lung cancer (NSCLC) resistance to the payload SN38. While SLFN11 is already recognized as a biomarker for drug

Turbine’s Virtual Lab is about to open its doors, and we’re inviting you to be among the first to experience it. This is your exclusive chance to see firsthand how Turbine’s Virtual Lab is transforming the way we simulate and mechanistically understand experiments in an

Let's meet at the AACR Annual Meeting! We will live demo our virtual lab at booth #4608. eu1.hubs.ly/H0jdYXb0 Team Turbine is also showcasing scientific results with 4 posters during the following sessions: 1️⃣ Characterization of chromosomal instability-related dependencies

One week to go until #AACR25 with recent news shaking up the industry: The FDA has announced plans to move away from mandatory animal testing in drug development, paving the way for human-relevant, in silico methods to take center stage. This step signals a future where virtual

✨We’re incredibly proud that one of Chicago’s iconic landmarks - the Willis Tower - will light up in Turbine colors during AACR, on April 27th from 7PM. We won’t say too much (just yet) because tomorrow, we’re announcing something big: the launch of our virtual lab over a

🌆 And here we are - with the Willis Tower lit up in Turbine colors! A proud moment for us, but also a beacon of everything we stand for: In our virtual lab, researchers across the globe can now run millions of in silico experiments in hours, investigate hypotheses across

What. A. Week. AACR 2025 in Chicago was a whirlwind-and for the first time, we had our own booth. Here’s the highlight reel: 🔹 We launched our virtual lab and let attendees dive into two inaugural modules: the Payload Selector and the Clinical Positioning Suite Explore them

🚨 In the news 🚨 We’re super excited-our CEO & Co-founder, Szabolcs Nagy, just got featured in PharmaCircle’s latest newsletter! This special issue dives into how AI is shaking up drug development and helping move beyond animal testing. Szabi shared how Turbine is opening its

What if we could simulate how a drug interacts with a human cell before it's ever tested in a wet lab? 💥 That’s the promise of AI-powered cell simulations, and it’s not science fiction. In the Scientist, Daniel Veres, our Co-founder & CSO, offering key insights on how this tech

🛠️“Evolution was the OG biohacker.” Here’s the kicker: biology isn’t random. It’s evolution’s billion-year optimization project. 🧬 ◾AlphaFold cracks (evolutionally relevant, organic) protein structures? Thank evolution’s rulebook. ◾AI predicts cell behavior? It’s mapping the

🚀 After launching our Virtual Lab demo at #AACR25, our ADC Payload Selector has now moved into production version, already serving its first users across the globe. Our Virtual Lab is a new way of working for scientists, a new scientific interface. It helps guide better